Interestingly, a closer examination of SAMHD1 mRNA levels in T- and B-ALL subgroups revealed further pronounced differences, which could be important for therapeutic outcome; for instance, SAMHD1 mRNA levels were equally low in Philadelphia (Ph)-like B-ALL and T-ALL patient samples [76]. Here, SAMHD1 is linked to acute lymphoblastic leukemia.